Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs IPCA LABS - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA IPCA LABS ABBOTT INDIA/
IPCA LABS
 
P/E (TTM) x 48.6 27.4 177.5% View Chart
P/BV x 15.9 8.5 185.9% View Chart
Dividend Yield % 0.4 0.1 305.0%  

Financials

 ABBOTT INDIA   IPCA LABS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
IPCA LABS
Mar-19
ABBOTT INDIA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs8,8341,042 847.8%   
Low Rs5,458590 924.8%   
Sales per share (Unadj.) Rs1,731.1298.6 579.7%  
Earnings per share (Unadj.) Rs211.935.0 605.5%  
Cash flow per share (Unadj.) Rs219.949.4 444.8%  
Dividends per share (Unadj.) Rs65.003.00 2,166.7%  
Dividend yield (eoy) %0.90.4 247.4%  
Book value per share (Unadj.) Rs945.2247.1 382.5%  
Shares outstanding (eoy) m21.25126.35 16.8%   
Bonus/Rights/Conversions -ESOS-  
Price / Sales ratio x4.12.7 151.1%   
Avg P/E ratio x33.723.3 144.6%  
P/CF ratio (eoy) x32.516.5 196.9%  
Price / Book Value ratio x7.63.3 228.9%  
Dividend payout %30.78.6 357.8%   
Avg Mkt Cap Rs m151,848103,108 147.3%   
No. of employees `0003.513.4 25.9%   
Total wages/salary Rs m4,3567,874 55.3%   
Avg. sales/employee Rs Th10,555.52,807.0 376.0%   
Avg. wages/employee Rs Th1,249.9585.8 213.4%   
Avg. net profit/employee Rs Th1,292.2329.0 392.8%   
INCOME DATA
Net Sales Rs m36,78637,732 97.5%  
Other income Rs m1,133577 196.4%   
Total revenues Rs m37,91938,309 99.0%   
Gross profit Rs m6,0476,901 87.6%  
Depreciation Rs m1691,824 9.3%   
Interest Rs m23189 11.9%   
Profit before tax Rs m6,9895,465 127.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4851,042 238.4%   
Profit after tax Rs m4,5034,422 101.8%  
Gross profit margin %16.418.3 89.9%  
Effective tax rate %35.619.1 186.4%   
Net profit margin %12.211.7 104.5%  
BALANCE SHEET DATA
Current assets Rs m27,61023,778 116.1%   
Current liabilities Rs m8,56910,975 78.1%   
Net working cap to sales %51.833.9 152.6%  
Current ratio x3.22.2 148.7%  
Inventory Days Days60104 58.0%  
Debtors Days Days2766 41.6%  
Net fixed assets Rs m1,05720,368 5.2%   
Share capital Rs m213253 84.1%   
"Free" reserves Rs m19,87330,971 64.2%   
Net worth Rs m20,08631,224 64.3%   
Long term debt Rs m01,409 0.0%   
Total assets Rs m29,40945,507 64.6%  
Interest coverage x311.630.0 1,040.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.8 150.9%   
Return on assets %15.410.1 151.9%  
Return on equity %22.414.2 158.3%  
Return on capital %34.917.3 201.5%  
Exports to sales %045.9 0.0%   
Imports to sales %016.6 0.0%   
Exports (fob) Rs mNA17,308 0.0%   
Imports (cif) Rs mNA6,266 0.0%   
Fx inflow Rs m36917,308 2.1%   
Fx outflow Rs m4,9186,266 78.5%   
Net fx Rs m-4,54911,042 -41.2%   
CASH FLOW
From Operations Rs m4,9914,923 101.4%  
From Investments Rs m-2,570-1,563 164.4%  
From Financial Activity Rs m-1,428-1,832 77.9%  
Net Cashflow Rs m9931,528 65.0%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 11.4 69.3%  
FIIs % 0.1 25.3 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 17.4 98.3%  
Shareholders   18,270 36,892 49.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE SCIENCES  DR. DATSONS LABS  WOCKHARDT  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 15, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - WYETH COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS